Adcetris 50 MG vials
Ended Awarded
- Contract number
- SPE2DB25FX1XL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,599
Award facts
- Contract value 100% obligated
- $40,598.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $40,598.90 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials. The contract, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, represents a discrete procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. This delivery order carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters and distribution operations.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in 2001, holds a substantial single-award IDC with DLA valued at $499.99 million through November 2026 under the SPE2DB program. This master contract authorizes DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities worldwide. Adcetris, a specialty oncology medication, exemplifies the company's role as a critical supplier of branded and specialized pharmaceuticals to the Department of Defense healthcare system. The company's established track record includes distribution of complex products such as biologics, specialty injections, and prescription medications essential to military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FX1XL?
SPE2DB25FX1XL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FX1XL worth?
The government has obligated $40,599 on SPE2DB25FX1XL.
Is contract SPE2DB25FX1XL an order under another contract?
Yes. SPE2DB25FX1XL is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1XL competed?
The extent of competition for SPE2DB25FX1XL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award